Neurology
The most recent articles from:
Neurology
-
Editorial Comment
Avoiding the costs of unrecognized psychological nonepileptic seizures.
-
Randomized Controlled Trial Multicenter Study
Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
To evaluate the efficacy and tolerability of levetiracetam (LEV) as adjunctive therapy in children (4 to 16 years) with treatment-resistant partial-onset seizures. ⋯ Levetiracetam adjunctive therapy administered at 60 mg/kg/day is efficacious and well tolerated in children with treatment-resistant partial seizures.